Home Kidswell Bio

Kidswell Bio

In operation
Post-IPO Round
Biopharmaceutical Manufacturer
Basic
Enterprise Profile

Basic Information

Kidswell Bio Corporation (formerly Gene Techno Science) engages in the research and development of biopharmaceutical products and biosimilars in Japan. The company develops drugs for the treatment of immune, cardiovascular, ophthalmic, infectious, and renal diseases, as well as oncology drugs. It also provides Filgrastim for cancer treatment.
Kidswell Bio Corporation
Tokyo,Tokyo,Japan
15~50 people
March 01, 2001
--

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Concept
Ophthalmology Tumor Cardiovascular Disease Immune System Diseases
Application Scenarios
Generic Drug Innovative Drugs